Senior Director
Alnylam Pharmaceuticals
Sudbury, Massachusetts, United States
Toxicologic Neuropathology of Novel Therapeutics (CE6)
Sunday, November 17, 2024
1:00 PM – 4:30 PM CT
RNAi Pharmacokinetics and Activity Assessment in CNS (CE6-5)
Sunday, November 17, 2024
3:30 PM – 4:00 PM CT